Get access to our best features
Get access to our best features
Published 1 month ago

ALS drug Relyvrio withdrawn from market after failed clinical trial

Summary by KRDO
By Mira Cheng, CNN (CNN) — Amylyx Pharmaceuticals announced Thursday that it has begun the process of voluntarily withdrawing its ALS drug, Relyvrio, from the market after it failed to prove efficacy in a large clinical trial. “Relyvrio will no longer be available for new patients as of today. Patients currently on therapy in the US and Canada who, in consultation with their physician, wish to stay on treatment can be transitioned to a free drug…

0 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 91% of the sources are Center
91% Center

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)